Latest News view all news

11/06/2023

New FDA approval for BMS in melanoma

09/19/2023

Pfizer Inc. is pleased to announce that the FDA has approved TALZENNA®

08/30/2023

KRAS G12C inhibitor evaluated in NSCLC patients with untreated CNS metastases

08/25/2023

FDA-approval in Multiple Myeloma

Upcoming Events view all events

 December 2023 
SMTWTFS
     12
3456789
10111213141516
17181920212223
24252627282930
31      

None at this time.

Corporate Members view all sponsors